Skip to main content


  • Poster presentation
  • Open Access

Our surgical procedure in acut thrombosis of stent graft using in treatment of pseudoaneurysm developing in popliteal anastomosis region of previous cross-over composite sequential femoro-popliteal bypass

Journal of Cardiothoracic Surgery20138 (Suppl 1) :P116

  • Published:


  • Warfarin
  • Lower Extremity
  • Acetylsalicylic Acid
  • Stent Graft
  • Popliteal Artery


Occlusion of femoro-popliteal bypass graft represents a limb and life-threatening condition requiring emergency intervention.


A 66-year-old man was admitted to our hospital on November 11, 2012. He had a painful, pulseless, and cold below-knee in right lower extremity. He had previous right cross-over composite sequential femoro-popliteal bypass. Angiography showed acute occlusion of cross-over composite femoro-popliteal bypass graft and stent graft used in treatment of pseudoaneurysm developing in popliteal anastomosis region of this graft. Proximal EPTFE graft was occluded with thrombus in arteriography.


Thrombectomy was performed with the 5F Fogarty balloon catheter and excessive thrombus was extracted. A thrombo-embolectomy was performed to the distal of popliteal artery, but thrombus was not detected in this region. The patient was performed a new interposition saphenous vein graft between the proximal EPTFE graft and distal popliteal artery. The patient received low-molecular weight heparin in postoperative period. He received warfarin and acetylsalicylic acid in follow-up. Right lower extremity pulses were palpable in postoperative period. Right lower extremity had good function in follow-up at 6 months.


We showed importance of saphenous vein graft bypass and thrombectomy in a case of having acute occlusion of cross-over composite sequential femoro-popliteal bypass.

Authors’ Affiliations

Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Cardiovascular Surgery, Izmir, Turkey


© Ergunes et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.